JPH08119874A - Production of suppressor of aids virus and cancer cell - Google Patents

Production of suppressor of aids virus and cancer cell

Info

Publication number
JPH08119874A
JPH08119874A JP6297806A JP29780694A JPH08119874A JP H08119874 A JPH08119874 A JP H08119874A JP 6297806 A JP6297806 A JP 6297806A JP 29780694 A JP29780694 A JP 29780694A JP H08119874 A JPH08119874 A JP H08119874A
Authority
JP
Japan
Prior art keywords
cancer cell
blood
aids
glucan
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6297806A
Other languages
Japanese (ja)
Inventor
Takumi Sogabe
工 曽我部
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP6297806A priority Critical patent/JPH08119874A/en
Publication of JPH08119874A publication Critical patent/JPH08119874A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE: To obtain a treating medicine comprising D fraction, β-glucan and an organogermanium and capable of strongly suppressing AIDS and cancer. CONSTITUTION: A D fraction contained in Grifola frondosa capable of strongly suppressing AIDS and β-glucan capable of strongly suppressing cancer cell are added to a solvent and extracted with the solvent to provide an extract. The extract is maximally concentrated by pressure-reducing method or pressure- heating method to afford a stock solution, which is then blended with an aqueous solution of an organogermanium [(G8CH2 CH2 COOH)2 O3 ] for eliminating pain and killing cancer cell and clarifying blood to provide the objective agent. The agent treats many diseases of many persons and clarifies blood and changes the constitutions of persons to constitutions which hardly get diseases.

Description

【発明の詳細な説明】 (1)発明の目的 本発明の第一目的は、エイズと癌を強力に抑制する治療
剤の開発。第二目的は、万人の万病を治療し、血液を清
浄化することによって病気にかかりにくい体質に改善す
ることにある。
DETAILED DESCRIPTION OF THE INVENTION (1) Object of the Invention The first object of the present invention is to develop a therapeutic agent that strongly suppresses AIDS and cancer. The second purpose is to treat all the illnesses of all and to improve the constitution by making the blood clean so as not to get sick.

(2)発明の構成 本発明の構成は、エイズを抑制するDフラクション物質
と癌を抑制するグルカン。痛みを取り除き癌細胞を殺
し、血液を清浄化する有機ゲルマニウムから成る。
(2) Structure of the Invention The structure of the present invention is a D fraction substance that suppresses AIDS and a glucan that suppresses cancer. It consists of organogermanium, which relieves pain and kills cancer cells and cleanses the blood.

(3)産業上の利用分野 舞茸より抽出される液剤1kgを作るに必要な舞茸は3
00kgである。世界のエイズ患者は400万人と発表
されているが、全員を治療するとすれば必要な液剤は約
2000屯と推定される。主原料の生舞茸は約60万屯
で舞茸産業の振興に貢献すると同時に搾り粕は養魚、畜
産の良質飼料となるのでこの分野に対しても貢献でき
る。
(3) Fields of industrial application The number of Maitake mushrooms required to make 1 kg of liquid medicine extracted from Maitake mushrooms is 3
It is 00 kg. It is announced that there are 4 million AIDS patients in the world, but it is estimated that about 2000 tons of liquid medicine will be needed to treat all of them. The main ingredient, raw maitake mushrooms, is about 600,000 tons and contributes to the promotion of the maitake mushroom industry. At the same time, since the squeezed lees are good feed for fish farming and livestock, it can also contribute to this field.

(4)従来の技術 現在、認可されているエイズ抑制剤はAZT、DDI、
DDCの3種であるが、何れも逆転写酵素阻害剤で強烈
な副作用があるうえにエイズウィルスに耐性が出来て薬
が効かなくなる。従って本格的な治療剤ではない。副作
用のないエイズウィルス抑制剤は、現在のところ開発さ
れていない。
(4) Conventional technology Currently approved AIDS inhibitors are AZT, DDI,
There are three types of DDC, all of which have strong side effects with reverse transcriptase inhibitors, and in addition, they can be resistant to AIDS virus and the drug becomes ineffective. Therefore, it is not a full-scale therapeutic agent. An AIDS virus inhibitor without side effects has not been developed so far.

(5)本発明が解決しようとする課題 本発明は前記(4)の実情に鑑み、エイズを治療するの
みならず癌細胞を抑制するグルカンとゲルマニウム、体
の痛みをとるエンドルフィン、血液をきれいにする酸素
(血液を汚す悪玉の血中水素と結合して水素を除く)
等、一薬万能の液剤を開発することが最大の課題であ
る。
(5) Problems to be Solved by the Present Invention In view of the above-mentioned situation (4), the present invention cleans not only the glucan and germanium that not only treat AIDS but also suppress cancer cells, endorphins that take pain in the body, and blood. Oxygen (combines with bad blood hydrogen that pollutes blood and removes hydrogen)
Therefore, the most important issue is to develop a universal drug solution.

(6)課題と解決するための手段 万病は体内酸素の欠乏によって発生する。これを防御す
る方法は体内酸素を増強して常にサラサラのよい血液を
持つことである。しかし体内酸素を増す薬はない。有機
ゲルマニウム分子は3ヶの酸素をつかんでおり血中に入
ると悪玉水素と結合して水となって排出され、血液がき
れいになる。きれいな血液が病気を治す。薬では完全に
病気が治らない。舞茸から抽出したエイズ抑制剤Dフラ
クションと癌抑制剤グルカンに有機ゲルマニウムを配合
すれば万病に対し有効に作用する生体防御食品が達成で
きる。
(6) Problems and means for solving the problem All the diseases are caused by lack of oxygen in the body. The way to prevent this is to increase the oxygen in the body and always have a good blood. However, there is no drug that increases oxygen in the body. The organic germanium molecule grabs 3 kinds of oxygen, and when it enters the blood, it combines with bad hydrogen and is discharged as water, which cleans the blood. Clean blood cures the disease. The medicine does not cure the disease completely. By adding an organic germanium to the AIDS inhibitor D fraction extracted from Maitake mushroom and the cancer inhibitor glucan, a bioprotective food that effectively acts against all diseases can be achieved.

(7)作用効果 本発明の作用効果を分析してその要点を説明すると次の
通りである。
(7) Action and effect The following is a description of the action and effect of the present invention and the main points thereof.

(イ)Dフラクション、HIVを強力に抑制する有効率
は70%(アメリカ病院の臨床試験結果) (ロ)グルカン、癌細胞を強力に抑制する。(神戸女子
薬科大学) (ハ)エンドルフィン、体内で痛みを抑えている物質。
これを増強すれば迅速に痛みがとれる(東北大学医学部
の試験) (ニ)有機ゲルマニウムは体内でインターフェロンを誘
発し、NK細胞を活性化する。活性化されたNK細胞は
約60時間で癌細胞を撲滅する。
(A) The effective rate of strongly suppressing D fraction and HIV is 70% (the results of clinical trials at American hospitals) (b) It strongly suppresses glucan and cancer cells. (Kobe Women's Pharmaceutical University) (C) Endorphin, a substance that suppresses pain in the body.
If this is enhanced, pain can be removed quickly (done in the Tohoku University School of Medicine). (D) Organic germanium induces interferon in the body and activates NK cells. Activated NK cells eradicate cancer cells in about 60 hours.

(ホ)有機ゲルマニウム元素の原子は4ヶの自由電子を
持っており、電子交換作用によって有害物電子を無害電
子に転換する。
(E) The atom of the organic germanium element has four free electrons, and converts harmful electrons into harmless electrons by the electron exchange action.

(ヘ)有機ゲルマニウムの分子の3本の手が、夫々酸素
をつかんでおり、血中の悪玉水素と結合して水にして流
し血液を清浄化する。
(F) Each of the three hands of the organic germanium molecule grabs oxygen, binds to bad hydrogen in the blood, and turns it into water to cleanse the blood.

実施例 本発明の実施は別紙生体防御剤の製造行程図の通りであ
る。
Example The practice of the present invention is as shown in the attached sheet for manufacturing a bioprotective agent.

発明の効果 本発明の効果を次ぎに列記する。Effects of the Invention The effects of the present invention are listed below.

(1)舞茸産業の育成と振興 (2)養魚、家畜などの安価な飼料の産出 (3)エイズ患者、癌患者の治療剤として有効率はエイ
ズ70%、癌60%である (4)きれいなサラサラの血液を作り万病治療に有効に
作用する。
(1) Fostering and promoting the maitake mushroom industry (2) Producing inexpensive feed for fish farming, livestock, etc. (3) Effectiveness as a therapeutic agent for AIDS patients and cancer patients is 70% AIDS and 60% cancer (4) It produces clean, smooth blood and acts effectively for all kinds of diseases.

(5)きれいな血液を持てば体質が改善され病気にかか
りにくくなる。
(5) Having clean blood improves your constitution and makes you less likely to get sick.

【図面の簡単な説明】[Brief description of drawings]

末尾添付の表は本発明の行程図である。 The table attached at the end is a process chart of the present invention.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】舞茸に微量含有するDフラクション物質と
グルカンと溶媒と加えて熱間抽出したエキスを減圧法又
は圧力加熱法によって最高限度に濃縮した原液に有機ゲ
ルマニウム〔(GeCHCHCOOH)〕を
水に溶かして所要量配合し、マイタケエキスの薬理効果
と有機ゲルマニウムの薬理効果の相乗効果を引き出し、
作用効果を高めたエイズウィルス、癌細胞抑制剤の製造
方法。
1. An organic germanium [(GeCH 2 CH 2 COOH) is added to a stock solution obtained by hot-extracting a D fraction substance, glucan, and a solvent, which are contained in a small amount in Maitake mushrooms, by a vacuum method or a pressure heating method. 2 O 3 ] is dissolved in water and mixed in a required amount to bring out the synergistic effect of the pharmacological effect of Maitake extract and the organic germanium,
A method for producing an AIDS virus and a cancer cell inhibitor having enhanced action and effect.
JP6297806A 1994-10-24 1994-10-24 Production of suppressor of aids virus and cancer cell Pending JPH08119874A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6297806A JPH08119874A (en) 1994-10-24 1994-10-24 Production of suppressor of aids virus and cancer cell

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6297806A JPH08119874A (en) 1994-10-24 1994-10-24 Production of suppressor of aids virus and cancer cell

Publications (1)

Publication Number Publication Date
JPH08119874A true JPH08119874A (en) 1996-05-14

Family

ID=17851415

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6297806A Pending JPH08119874A (en) 1994-10-24 1994-10-24 Production of suppressor of aids virus and cancer cell

Country Status (1)

Country Link
JP (1) JPH08119874A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0893449A4 (en) * 1996-03-08 1999-04-07 Yukiguni Maitake Co Ltd Antitumor substance extracted from hen-of-the-woods

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54147932A (en) * 1978-05-08 1979-11-19 Asai Germanium Res Inst Antiicancer agent
JPS59210901A (en) * 1983-05-17 1984-11-29 Nippon Kinoko Kenkyusho Glucan having beta-1,6 bond-containing main chain, obtained from maitake and antineoplastic agent comprising same
JPS6058925A (en) * 1983-09-09 1985-04-05 Nippon Beet Sugar Mfg Co Ltd Antineoplastic substance
JPS62209091A (en) * 1986-03-08 1987-09-14 Nippon Beet Sugar Mfg Co Ltd Antitumor active polysaccharide
JPS63307821A (en) * 1987-06-05 1988-12-15 Asai Gerumaniumu Kenkyusho:Kk Pharmaceutical preparation for treating aids virus infection
JPH02134318A (en) * 1988-11-15 1990-05-23 Sanwa Kagaku Kenkyusho Co Ltd Interferon-production promoting agent and interferon-production promoting composition containing the same
JPH02145517A (en) * 1988-11-27 1990-06-05 Sanwa Kagaku Kenkyusho Co Ltd Preventive and remedy for crisis of aids and treating composition thereof
JPH05336918A (en) * 1992-06-05 1993-12-21 Mitsuo Nakajima Anti-aids food and drink prepared from grifola frondosa and its preparation

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54147932A (en) * 1978-05-08 1979-11-19 Asai Germanium Res Inst Antiicancer agent
JPS59210901A (en) * 1983-05-17 1984-11-29 Nippon Kinoko Kenkyusho Glucan having beta-1,6 bond-containing main chain, obtained from maitake and antineoplastic agent comprising same
JPS6058925A (en) * 1983-09-09 1985-04-05 Nippon Beet Sugar Mfg Co Ltd Antineoplastic substance
JPS62209091A (en) * 1986-03-08 1987-09-14 Nippon Beet Sugar Mfg Co Ltd Antitumor active polysaccharide
JPS63307821A (en) * 1987-06-05 1988-12-15 Asai Gerumaniumu Kenkyusho:Kk Pharmaceutical preparation for treating aids virus infection
JPH02134318A (en) * 1988-11-15 1990-05-23 Sanwa Kagaku Kenkyusho Co Ltd Interferon-production promoting agent and interferon-production promoting composition containing the same
JPH02145517A (en) * 1988-11-27 1990-06-05 Sanwa Kagaku Kenkyusho Co Ltd Preventive and remedy for crisis of aids and treating composition thereof
JPH05336918A (en) * 1992-06-05 1993-12-21 Mitsuo Nakajima Anti-aids food and drink prepared from grifola frondosa and its preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0893449A4 (en) * 1996-03-08 1999-04-07 Yukiguni Maitake Co Ltd Antitumor substance extracted from hen-of-the-woods

Similar Documents

Publication Publication Date Title
Mahajan et al. Miraculous benefits of cow urine: a review
EP0530060B1 (en) Medication based on neutralised sulphur derivatives
CN1883599A (en) Chinese medicinal composition for treating women's episioitis or colpitis and method for preparing same
CN1823929A (en) Medicine for treating dandruff
JPH08119874A (en) Production of suppressor of aids virus and cancer cell
JP2003265139A (en) Method for producing bio-protective immunogenic food for cancer cell and aids virus
CN1030580C (en) Chinese medicine preparation and wet cloth for cleaning pudenda
CN1723936A (en) Traditional Chinese medicine for treating depressive disorders, and its prepn. method
CN107050060A (en) Treat psoriasic externally applied drug and pharmaceutical composition
CN109091564A (en) It is a kind of to sterilize strong skin cleaning solution and preparation method thereof
KR19990083931A (en) Soap for Itching Symptoms Improvement and Manufacturing Method thereof
CN1264591A (en) Medicine for treating psoriasis and preparing process thereof
CN102008586A (en) Effective drug for treating skin disease
Mahyeddin et al. An islamic view on the utilization of leeches and worms for pharmaceutical and cosmetic purposes
CN102552885A (en) Piles and anus internal epithelium and rectum mucous epithelium cell anti-inflammation celltrex made of marine organisms
Manderson et al. Chronicities of illness
Rajput et al. Honey-Health Benefits of Golden Liquid
JP2003040783A (en) Tungstic acid salt or molybdic acid salt and addition product of reishi spore useful as pharmaceutical product and health food
Belekar et al. VERSATILE USES OF INDIAN COW URINE: A REVIEW
RU2156616C1 (en) Method for treating and normalizing health of human organism
WO2006118488A2 (en) Processed sunflower black seed oil and use thereof in pharamac eut i cal and cosmetic compositions
EP2825184A1 (en) Compositions and methods for treatment of pain
CN107496829A (en) A kind of turmeric giant knotweed wind-expelling pain-stopping dip and preparation method thereof
CN1506076A (en) Externally appied medicine for relieving pain and diminishing inflammation
CN102327320B (en) Chinese medicine for treating stomatitis by purging liver-fire